Targeting the metabolic fingerprint of amino acids to identify novel metabolic characteristics in osteosarcoma patients undergoing anthracycline treatment
Abstract Anthracycline (ANT) is a potent chemotherapeutic drug used in the treatment of solid tumors. However, its clinical use is limited by the occurrence of severe cardiotoxicity, which can lead to cardiac dilation and heart failure. Unfortunately, the exact mechanism behind this cardiotoxicity i...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2026-02-01
|
| Serija: | Scientific Reports |
| Teme: | |
| Online pristup: | https://doi.org/10.1038/s41598-026-41411-8 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|